The U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, a cannabis-derived investigational treatment being developed as a non-opioid option for chronic low back pain. VERTANICAL announced today that the designation was granted after two randomized, controlled Phase 3 trials found that VER-01 produced significant pain reductions, was generally well tolerated and …
Alaska Senate Unanimously Passes Bill to Overhaul Industrial Hemp Rules
The Alaska Senate has unanimously passed a bill that would make several changes to the state’s industrial hemp program, including new rules for testing, transportation, enforcement and smaller growers. Senate Bill 208, sponsored by State Senator Jesse Bjorkman (R), was passed by the Senate in a 20 to 0 vote. The measure is now moving …
Florida Medical Cannabis Sales Surpass 8.2 Billion mg of THC in 2026, Flower Sales Near 3 Million Ounces
Florida medical marijuana sales continued their steady climb in mid-May, with dispensaries selling another 424.9 million milligrams of THC during the latest reporting period. According to the newest weekly update from the Office of Medical Marijuana Use, covering May 8 through May 14, patients purchased 424,888,297 milligrams of THC and 147,162.633 ounces of smokable marijuana …
Report: Global Cannabis Tourism Market Projected to Reach $26.9 Billion by 2032
The global cannabis tourism market is projected to more than double over the next several years, reaching $26.9 billion by 2032, according to a new market report released today. The report, from Research and Markets, estimates the cannabis tourism market was valued at $11 billion in 2025. It projects the market will grow at a …
Global Cannabis Report Finds Pricing Compression Reshaping Emerging Markets
A new global report from the Global Cannabis Network Collective and Whitney Economics finds that pricing compression is becoming one of the clearest signs of cannabis market maturity, especially as emerging markets expand across Europe, Latin America and other regions. The report, What You Need to Know: Pricing Compression and Its Impact on International Cannabis …
Minnesota Legislature Passes Omnibus Cannabis Bill, Sending it to Governor Walz
The Minnesota Legislature gave final approval today to an omnibus marijuana bill that would make a wide range of changes to the state’s legal marijuana system, sending the proposal to the governor. Senate File 4401, sponsored by State Senator David Dibble (D), State Senator Lindsey Port (D) and State Representative Jessica Hanson (D), was passed …
Clinical Trial: Marijuana Oil With THC and CBD May Reduce Pain and Improve Sleep in Fibromyalgia Patients
A clinical trial published yesterday found that a marijuana oil containing equal amounts of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) was well tolerated and may help reduce pain, improve sleep and lessen the overall impact of fibromyalgia. The study, published in Pain Research and Management, was conducted by researchers from Southern Cross University, Griffith University and …
Study: Cannabinoid Capsules Linked to Pain Relief in Fibromyalgia and Arthritis Patients
A new study published in Clinical Therapeutics found that multiple cannabinoid combinations were associated with improvements in pain and related symptoms among patients with fibromyalgia, rheumatoid arthritis and osteoarthritis of the knee and/or hip. The study, conducted by researchers from the University of Michigan Medical School and the University at Buffalo, examined whether different combinations …
DEA Says Medical Marijuana Registration Question Won’t Automatically Block Applicants
The Drug Enforcement Administration (DEA) told the Cannabis Business Times that a question on its new medical marijuana registration form asking applicants if they previously handled controlled substances without federal authorization is not intended to block state-licensed businesses from receiving registration. The issue centers on a question included in DEA’s Medical Marijuana Dispensary Information Submission …
Washington D.C. Medical Marijuana Sales Hit Record $10.4 Million in April as Patient Count Tops 116,000
Washington D.C.’s medical marijuana market reached a new monthly high in April, with total sales hitting $10,404,293, according to a report (PDF) from the Alcoholic Beverage and Cannabis Administration. That’s up from $9,300,768 in March and $8,521,316 in February, and marks a 16.2% increase from the $8,955,050 sold in April 2025. The district’s patient base …
Trending Articles
